Literature DB >> 25189424

The immune response and antibacterial therapy.

Olachi Anuforom1, Graham R Wallace, Laura V Piddock.   

Abstract

The host's immune defence mechanisms are indispensable factors in surviving bacterial infections. However, in many circumstances, the immune system alone is inadequate. Since the 1940s, the use of antibacterial therapy has saved millions of lives, improving the span and quality of life of individuals. Unfortunately, we are now facing an era where antibacterial agents are threatened by resistance. In addition to targeting bacteria, some antibacterial agents affect various aspects of the immune response to infection. Since many antibacterial drugs are failing in efficacy due to resistance, it has been strongly suggested that any synergy between these drugs and the immune response be exploited in the treatment of bacterial infections. This review explores the influence of antibacterial therapy on the immune response and new approaches that could exploit this interaction for the treatment of bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25189424     DOI: 10.1007/s00430-014-0355-0

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  86 in total

1.  Effects of antibiotics on acquired immunity in vivo--current state of knowledge.

Authors:  M Pomorska-Mól; Z Pejsak
Journal:  Pol J Vet Sci       Date:  2012       Impact factor: 0.821

2.  Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.

Authors:  C Seral; M Barcia-Macay; M P Mingeot-Leclercq; P M Tulkens; F Van Bambeke
Journal:  J Antimicrob Chemother       Date:  2005-02-24       Impact factor: 5.790

Review 3.  Non-typhoid Salmonella in renal transplant recipients: a report of twenty cases and review of the literature.

Authors:  J M Dhar; A A al-Khader; M al-Sulaiman; M K al-Hasani
Journal:  Q J Med       Date:  1991-03

4.  Beta-lactam antibiotics modulate T-cell functions and gene expression via covalent binding to cellular albumin.

Authors:  Felix Mor; Irun R Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

5.  An open-label, prospective study of an oral polyvalent bacterial lysate (Luivac) in the treatment of recurrent respiratory tract infections in Thai patients.

Authors:  Perapun Jareoncharsri; Chaweewan Bunnag; Prayuth Tunsuriyawong; Paraya Assanasane; Siriporn Voraprayoon; Bangon Pinkaew
Journal:  Asian Pac J Allergy Immunol       Date:  2003-12       Impact factor: 2.310

Review 6.  In vitro susceptibility vs. in vivo efficacy of various antimicrobial agents against the Bacteroides fragilis group.

Authors:  I Brook
Journal:  Rev Infect Dis       Date:  1991 Nov-Dec

7.  Listerial meningitis and renal allografts: a life-threatening affinity.

Authors:  F A Holden; J E Kaczmer; C C Kinahan
Journal:  Postgrad Med       Date:  1980-12       Impact factor: 3.840

Review 8.  Management of infections in the neutropenic patient.

Authors:  Kenneth V I Rolston
Journal:  Annu Rev Med       Date:  2004       Impact factor: 13.739

9.  Infection regulates pro-resolving mediators that lower antibiotic requirements.

Authors:  Nan Chiang; Gabrielle Fredman; Fredrik Bäckhed; Sungwhan F Oh; Thad Vickery; Birgitta A Schmidt; Charles N Serhan
Journal:  Nature       Date:  2012-04-25       Impact factor: 49.962

10.  Whole-animal chemical screen identifies colistin as a new immunomodulator that targets conserved pathways.

Authors:  Yun Cai; Xiou Cao; Alejandro Aballay
Journal:  mBio       Date:  2014-08-12       Impact factor: 7.867

View more
  7 in total

1.  Sulfamethoxazole drug stress upregulates antioxidant immunomodulatory metabolites in Escherichia coli.

Authors:  Hyun Bong Park; Zheng Wei; Joonseok Oh; Hao Xu; Chung Sub Kim; Rurun Wang; Thomas P Wyche; Grazia Piizzi; Richard A Flavell; Jason M Crawford
Journal:  Nat Microbiol       Date:  2020-07-27       Impact factor: 17.745

2.  Antibiotic-Induced Changes to the Host Metabolic Environment Inhibit Drug Efficacy and Alter Immune Function.

Authors:  Jason H Yang; Prerna Bhargava; Douglas McCloskey; Ning Mao; Bernhard O Palsson; James J Collins
Journal:  Cell Host Microbe       Date:  2017-11-30       Impact factor: 21.023

3.  Preventing Data Ambiguity in Infectious Diseases with Four-Dimensional and Personalized Evaluations.

Authors:  Michelle J Iandiorio; Jeanne M Fair; Stylianos Chatzipanagiotou; Anastasios Ioannidis; Eleftheria Trikka-Graphakos; Nikoletta Charalampaki; Christina Sereti; George P Tegos; Almira L Hoogesteijn; Ariel L Rivas
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

Review 4.  Nature and Consequences of Biological Reductionism for the Immunological Study of Infectious Diseases.

Authors:  Ariel L Rivas; Gabriel Leitner; Mark D Jankowski; Almira L Hoogesteijn; Michelle J Iandiorio; Stylianos Chatzipanagiotou; Anastasios Ioannidis; Shlomo E Blum; Renata Piccinini; Athos Antoniades; Jane C Fazio; Yiorgos Apidianakis; Jeanne M Fair; Marc H V Van Regenmortel
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

Review 5.  Linezolid and Its Immunomodulatory Effect: In Vitro and In Vivo Evidence.

Authors:  Jin Wang; Lei Xia; Rui Wang; Yun Cai
Journal:  Front Pharmacol       Date:  2019-11-28       Impact factor: 5.810

Review 6.  Antimicrobial Activity of Lactoferrin-Related Peptides and Applications in Human and Veterinary Medicine.

Authors:  Natascia Bruni; Maria Teresa Capucchio; Elena Biasibetti; Enrica Pessione; Simona Cirrincione; Leonardo Giraudo; Antonio Corona; Franco Dosio
Journal:  Molecules       Date:  2016-06-11       Impact factor: 4.411

Review 7.  Bacterial antibiotic resistance development and mutagenesis following exposure to subinhibitory concentrations of fluoroquinolones in vitro: a systematic review of the literature.

Authors:  Carly Ching; Ebiowei S F Orubu; Indorica Sutradhar; Veronika J Wirtz; Helen W Boucher; Muhammad H Zaman
Journal:  JAC Antimicrob Resist       Date:  2020-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.